Fsry Pharma Private Limited
About Fsry Pharma Private Limited
Data last updated:
Fsry Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 22 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2019PTC134266. Its GSTIN is 36AADCF8042R1Z2 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Riyaz Mohiuddin Mohammed and Yazdan Al Yousufi Mohammed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.88 Lakh. For the same year it recorded a net profit of ₹29,952 (net margin 0.8%) and EBITDA of ₹40,475 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 49% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH No 2 – 5 – 26/H/157 Flat No 157 Hh Hs, Upperpally Near Pillar No 202, Hyderabad, Telangana, India – 500048
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Fsry Pharma Private Limited
The main business activity of Fsry Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fsry Pharma Private Limited FY 2025 filings available
Fsry Pharma Private Limited reported revenue of ₹37.88 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Fsry Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Fsry Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹40,475 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29,952 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Fsry Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fsry Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Fsry Pharma Private Limited
Fsry Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ritisha Enterprises Private Limited | ₹37.9 Lakh (FY 2022) | •••• | •••• | 1672.0% | •••• | Hyderabad, Telangana, India |
| Polyfib Creations Private Limited | ₹37.9 Lakh (FY 2016) | •••• | •••• | 339.0% | •••• | Coimbatore, Tamil Nadu, India |
| Shree Vallabh International Private Limited | ₹37.9 Lakh (FY 2018) | •••• | •••• | -85.0% | •••• | Jaipur, Rajasthan, India |
| Allianz Mechanization India Private Limited | ₹37.89 Lakh (FY 2025) | •••• | •••• | -14.0% | •••• | Bangalore, Karnataka, India |
| Futurewell Pharmaceuticals Private Limited | ₹37.89 Lakh (FY 2024) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Fsry Pharma Private Limited this company | ₹37.88 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Petropros Private Limited | ₹37.88 Lakh (FY 2022) | •••• | •••• | •••• | Virudhunagar, Tamil Nadu, India | |
| Stable Consumer Care Services Private Limited | ₹37.87 Lakh (FY 2021) | •••• | •••• | 317.0% | •••• | Jhalawar, Rajasthan, India |
| Twistex Commerce Private Limited | ₹37.87 Lakh (FY 2025) | •••• | •••• | 78.0% | •••• | Kolkata, West Bengal, India |
| SRS Mining Equipments Private Limited | ₹37.86 Lakh (FY 2025) | •••• | •••• | 96.0% | •••• | Gwalior, Madhya Pradesh, India |
| Himcure Pharmaceuticals Private Limited | ₹37.86 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Rampur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Fsry Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Fsry Pharma Private Limited
Fsry Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Riyaz Mohiuddin Mohammed | Director | 22 Jul 2019 | 7 Years 2 Months | Current |
| Yazdan Al Yousufi Mohammed | Director | 22 Jul 2019 | 7 Years 2 Months | Current |
Ownership and Shareholding of Fsry Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Fsry Pharma Private Limited
Fsry Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Fsry Pharma Private Limited
Employment history and EPFO contributions of people linked to Fsry Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fsry Pharma Private Limited
Fsry Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Riyaz Mohiuddin Mohammed was appointed as Director on 22 Jul 2019.
Credit Ratings, Litigation & Regulatory Alerts for Fsry Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fsry Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fsry Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fsry Pharma Private Limited
Fsry Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCF8042R1Z2 | Telangana | Active | 09 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fsry Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fsry Pharma Private Limited
Fsry Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 22 July 2019 (7+ years old) and is registered under CIN U24299TG2019PTC134266.
Fsry Pharma reported revenue of ₹37.88 Lakh for FY 2025.
Fsry Pharma has 2 current directors:
- Riyaz Mohiuddin Mohammed - Director
- Yazdan Al Yousufi Mohammed - Director
Fsry Pharma reported a net profit of ₹29,952 (net margin 0.8%) and EBITDA of ₹40,475 (EBITDA margin 1.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Fsry Pharma is 19% over three years and 49% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Fsry Pharma is 36AADCF8042R1Z2, registered in Telangana.
The CIN (Corporate Identification Number) of Fsry Pharma is U24299TG2019PTC134266. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fsry Pharma was incorporated on 22 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Fsry Pharma by revenue are Ritisha Enterprises Private Limited, Polyfib Creations Private Limited, Shree Vallabh International Private Limited, Allianz Mechanization India Private Limited, Futurewell Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Riyaz Mohiuddin Mohammed was appointed as Director on 22 Jul 2019. Yazdan Al Yousufi Mohammed was appointed as Director on 22 Jul 2019.
The registered office of Fsry Pharma is at H No 2 – 5 – 26H157 Flat No 157 Hh Hs, Upperpally Near Pillar No 202, Hyderabad, Telangana, India – 500048.